1. Lyseng-Williamson KA. Levetiracetam: a review of its use in epilepsy. Drugs. 2011; 71:489–514. PMID:
21395360.
2. Sethi NK, Sethi PK, Torgovnick J, Arsura E, Cukierwar F. Asymptomatic elevation of liver enzymes due to levetiracetam: a case report. Drug Metabol Drug Interact. 2013; 28:123–124. PMID:
23420283.
Article
3. Shahbaz N, Younus SM, Khan SA, Ain Q, Khan MA, Memon MH. Levetiracetam induced increase in creatine phosphokinase levels. J Coll Physicians Surg Pak. 2017; 27:S63–S64. PMID:
28302251.
4. Broli M, Provini F, Naldi I, Bisulli F, Sama C, Baruzzi A, et al. Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy. Epileptic Disord. 2010; 12:81–82. PMID:
20159672.
Article
5. Hakami T, O'Brien TJ, Petty SJ, Sakellarides M, Christie J, Kantor S, et al. Monotherapy with levetiracetam versus older AEDs: a randomized comparative trial of effects on bone health. Calcif Tissue Int. 2016; 98:556–565. PMID:
26842957.
Article
6. Xiong N, Hou L, Lu N, Mohamed AA, Wang T, Huang Y. Probable levetiracetam-related serum alkaline phosphatase elevation. BMC Neurol. 2012; 12:97. PMID:
22994584.
Article